pegfilgrastim
Little Difference in Same-Day Versus Next-Day Pegfilgrastim
A retrospective analysis of breast cancer patients found no significant difference in neutropenia-related events ...
DECEMBER 4, 2023
FDA Approves Fulphila, First Biosimilar to Neulasta
Mylan's Fulphila is the first biosimilar to Neulasta to decrease the chance of infection as suggested by febrile ...
JUNE 4, 2018
Load more